SECTION I / FOUNDATIONS
CHAPTER 094 MIN READ

Low-Density Lipoproteins

Why "Bad Cholesterol" Is the Wrong Way to Say It

Luis F. Aparicio, MD, FACE
In this chapter

Why This Matters

Low-density lipoproteins (LDL) are among the most studied particles in medicine. For decades, LDL has been labeled "bad cholesterol," yet this description oversimplifies its biology and has led to widespread misunderstanding. LDL is not inherently harmful. It performs an essential physiological function by delivering cholesterol to cells throughout the body. The problem arises when LDL particles remain in the circulation long enough to enter and become retained within the arterial wall.

What Is LDL?

LDL is a cholesterol-rich lipoprotein formed primarily through the progressive metabolism of VLDL. As VLDL loses triglycerides and passes through the intermediate-density lipoprotein stage, it is remodeled into LDL.

Each LDL particle contains a single molecule of ApoB-100, which serves as both its structural backbone and the ligand that allows it to bind LDL receptors.

Because much of its triglyceride content has already been removed, LDL is enriched in cholesterol and cholesteryl esters, making it the principal carrier of cholesterol in the circulation.

The Physiological Role of LDL

The primary function of LDL is to deliver cholesterol to cells throughout the body.

Cells require cholesterol to maintain membrane integrity, synthesize steroid hormones, produce bile acids, generate vitamin D, and support numerous cellular processes. LDL transports this cholesterol from the liver to peripheral tissues, where it is taken up through LDL receptor-mediated endocytosis.

Under normal physiological conditions, this transport system is efficient, tightly regulated, and essential for life.

LDL Receptor-Mediated Uptake

Cells acquire cholesterol from LDL by expressing LDL receptors on their surface.

When ApoB-100 binds to the LDL receptor, the entire particle is internalized into the cell. Lysosomal enzymes degrade the lipoprotein, releasing free cholesterol for immediate cellular use, storage as cholesteryl esters, or regulation of intracellular cholesterol synthesis.

As intracellular cholesterol increases, LDL receptor expression decreases and cholesterol synthesis slows, maintaining cholesterol homeostasis.

LDL and Atherosclerosis

LDL becomes clinically important because it is capable of entering the arterial wall.

Most LDL particles pass into and out of the arterial intima without consequence. Atherosclerosis begins when ApoB-containing LDL particles become retained within the extracellular matrix of the arterial wall. Once retained, they undergo chemical modification, stimulate inflammation, and initiate the cascade that ultimately leads to plaque formation.

The development of atherosclerosis therefore depends not simply on the presence of LDL, but on the cumulative exposure of the arterial wall to circulating ApoB-containing particles and their retention within the vessel wall.

LDL Particle Number

Not all LDL profiles carry the same cardiovascular risk.

Two individuals may have identical LDL cholesterol concentrations but markedly different numbers of LDL particles. Smaller LDL particles carry less cholesterol per particle, meaning a greater number of particles may be required to transport the same amount of cholesterol.

Because every LDL particle contains one ApoB molecule, ApoB provides a direct estimate of LDL particle number and often reflects cardiovascular risk more accurately than LDL cholesterol alone.

Clinical Relevance

Elevated LDL remains one of the strongest modifiable risk factors for atherosclerotic cardiovascular disease.

Lowering the concentration of circulating ApoB-containing LDL particles reduces the likelihood that these particles will become retained within the arterial wall. This principle forms the foundation of contemporary lipid-lowering therapy and explains the benefits of statins, ezetimibe, PCSK9 inhibitors, and other therapies that increase LDL clearance.

Clinical Pearls

  • LDL is the principal carrier of cholesterol in the circulation.
  • LDL is formed through the progressive metabolism of VLDL.
  • Every LDL particle contains one ApoB-100 molecule.
  • LDL delivers cholesterol to peripheral tissues through LDL receptors.
  • Cardiovascular risk is determined by the number and retention of LDL particles rather than by the cholesterol molecule itself.

Common Misconceptions

Misconception: LDL is "bad cholesterol."

Reality: LDL is an essential lipoprotein that delivers cholesterol to cells. Disease develops when excessive numbers of LDL particles become retained within the arterial wall.

Misconception: LDL cholesterol measures the number of LDL particles.

Reality: LDL cholesterol measures the amount of cholesterol carried within LDL particles, not the number of particles themselves.

Misconception: All LDL particles carry the same amount of cholesterol.

Reality: The cholesterol content of individual LDL particles varies considerably, making LDL cholesterol an imperfect estimate of particle number.

Clinical Bottom Line

LDL is an essential cholesterol transport particle that plays a vital role in normal physiology. Its contribution to atherosclerosis depends not on its normal biological function, but on the number of circulating ApoB-containing particles and their cumulative retention within the arterial wall.

From The Lipoprotein & Cardiometabolic Handbook, a companion to Counting What Counts. Read the medical disclaimer.